Figure 4.
Cumulative percentage of patients prescribed at least 1 pharmacogenomic drugs over 20 years. As we did not have pre‐1993 prescribing data, we excluded patients who were prescribed a pharmacogenomic drug at any time in 1993 and then looked for first exposure afterwards.